electroCore FY2024 revenue $25.2M (+57% YoY); net loss narrows to $11.9M

electroCore, Inc.

Full year 2024 net sales of $25.2M, up 57% from $16.0M in 2023, driven by 85% growth in VA channel and 174% increase in Truvaga.
GAAP net loss $11.9M ($1.59 EPS) vs $18.8M ($3.42 EPS) in 2023; Adjusted EBITDA net loss $9.0M vs $15.4M.
Gross margin improved to 85% from 83%; cash and securities $12.2M at Dec 31, 2024 vs $10.6M a year ago.
Operating expenses $33.6M, up slightly from $32.5M; R&D down to $2.4M from $5.3M on reduced Truvaga Plus development.
Company cites pending acquisition of NeuroMetrix as part of inorganic expansion strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.